S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Li Auto smashes estimates proving EVs can be profitable
Get ready for Christmas shopping-sprees with these 2 winners
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Li Auto smashes estimates proving EVs can be profitable
Get ready for Christmas shopping-sprees with these 2 winners
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Li Auto smashes estimates proving EVs can be profitable
Get ready for Christmas shopping-sprees with these 2 winners
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Li Auto smashes estimates proving EVs can be profitable
Get ready for Christmas shopping-sprees with these 2 winners

Kennedy-Wilson Stock Price, News & Analysis (NYSE:KW)

$11.48
+0.08 (+0.70%)
(As of 11/28/2023 ET)
Compare
Today's Range
$11.22
$11.50
50-Day Range
$10.93
$15.78
52-Week Range
$10.68
$18.90
Volume
641,882 shs
Average Volume
982,728 shs
Market Capitalization
$1.60 billion
P/E Ratio
N/A
Dividend Yield
8.36%
Price Target
$11.00

Kennedy-Wilson MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.50 Rating Score
Upside/​Downside
4.2% Downside
$11.00 Price Target
Short Interest
Bearish
6.14% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-2.93
Upright™ Environmental Score
News Sentiment
1.11mentions of Kennedy-Wilson in the last 14 days
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
$1.23 M Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.49 out of 5 stars

Finance Sector

799th out of 860 stocks

Real Estate Industry

20th out of 23 stocks


KW stock logo

About Kennedy-Wilson Stock (NYSE:KW)

Kennedy-Wilson Holdings, Inc., together with its subsidiaries, operates as a real estate investment company. The company owns, operates, and invests in real estate both on its own and through its investment management platform. It focuses on multifamily and office properties located in the Western United States, the United Kingdom, Ireland, Spain, Italy, and Japan. The company had ownership interests in multifamily units, office space, retail and industrial space, and a hotel. It is also involved in the development, redevelopment, and entitlement of real estate properties. The company was founded in 1977 and is headquartered in Beverly Hills, California.

KW Stock Price History

KW Stock News Headlines

Kennedy-Wilson (NYSE: KW)
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Kennedy-Wilson: Q3 Earnings Snapshot
Kennedy Wilson Reports Third Quarter 2023 Results
Kennedy Wilson to Announce Third Quarter 2023 Earnings
Kennedy Wilson Reports Second Quarter 2023 Results
See More Headlines
Receive KW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kennedy-Wilson and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 10/5 Dividend
9/28/2023
Dividend Payable
10/05/2023
Last Earnings
11/01/2023
Today
11/29/2023
Ex-Dividend for 1/4 Dividend
12/28/2023
Fiscal Year End
12/31/2023
Dividend Payable
1/04/2024
Next Earnings (Estimated)
2/20/2024

Industry, Sector and Symbol

Industry
Real estate
Sub-Industry
Real Estate Services
Sector
Finance
CUSIP
48939810
Employees
260
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$11.00
High Stock Price Target
$16.00
Low Stock Price Target
$6.00
Potential Upside/Downside
-4.2%
Consensus Rating
Reduce
Rating Score (0-4)
1.50
Research Coverage
2 Analysts

Profitability

Net Income
$93.70 million
Pretax Margin
-1.05%

Debt

Sales & Book Value

Annual Sales
$540 million
Cash Flow
$3.19 per share
Book Value
$10.29 per share

Miscellaneous

Free Float
106,355,000
Market Cap
$1.60 billion
Optionable
Optionable
Beta
1.18
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report














KW Stock Analysis - Frequently Asked Questions

Should I buy or sell Kennedy-Wilson stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Kennedy-Wilson in the last twelve months. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" KW shares.
View KW analyst ratings
or view top-rated stocks.

What is Kennedy-Wilson's stock price target for 2024?

2 brokerages have issued twelve-month target prices for Kennedy-Wilson's stock. Their KW share price targets range from $6.00 to $16.00. On average, they anticipate the company's stock price to reach $11.00 in the next year. This suggests that the stock has a possible downside of 4.2%.
View analysts price targets for KW
or view top-rated stocks among Wall Street analysts.

How have KW shares performed in 2023?

Kennedy-Wilson's stock was trading at $15.73 at the beginning of 2023. Since then, KW stock has decreased by 27.0% and is now trading at $11.48.
View the best growth stocks for 2023 here
.

Are investors shorting Kennedy-Wilson?

Kennedy-Wilson saw a increase in short interest in November. As of November 15th, there was short interest totaling 7,260,000 shares, an increase of 19.0% from the October 31st total of 6,100,000 shares. Based on an average daily trading volume, of 925,400 shares, the days-to-cover ratio is presently 7.8 days. Approximately 6.1% of the shares of the stock are sold short.
View Kennedy-Wilson's Short Interest
.

When is Kennedy-Wilson's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 20th 2024.
View our KW earnings forecast
.

How were Kennedy-Wilson's earnings last quarter?

Kennedy-Wilson Holdings, Inc. (NYSE:KW) posted its quarterly earnings data on Wednesday, November, 1st. The financial services provider reported ($0.33) EPS for the quarter, missing the consensus estimate of $0.44 by $0.77. The financial services provider had revenue of $141.30 million for the quarter. Kennedy-Wilson had a positive trailing twelve-month return on equity of 2.98% and a negative net margin of 7.92%.

How often does Kennedy-Wilson pay dividends? What is the dividend yield for Kennedy-Wilson?

Kennedy-Wilson declared a quarterly dividend on Wednesday, November 1st. Investors of record on Friday, December 29th will be given a dividend of $0.24 per share on Thursday, January 4th. This represents a $0.96 annualized dividend and a dividend yield of 8.36%. The ex-dividend date of this dividend is Thursday, December 28th.
Read our dividend analysis for KW
.

Is Kennedy-Wilson a good dividend stock?

Kennedy-Wilson (NYSE:KW) pays an annual dividend of $0.96 per share and currently has a dividend yield of 8.32%. KW has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for KW.

What is William J. McMorrow's approval rating as Kennedy-Wilson's CEO?

19 employees have rated Kennedy-Wilson Chief Executive Officer William J. McMorrow on Glassdoor.com. William J. McMorrow has an approval rating of 63% among the company's employees. This puts William J. McMorrow in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Kennedy-Wilson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Kennedy-Wilson investors own include Verizon Communications (VZ), Bank of America (BAC), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), Advanced Micro Devices (AMD), Cisco Systems (CSCO), Johnson & Johnson (JNJ), AT&T (T) and QUALCOMM (QCOM).

Who are Kennedy-Wilson's major shareholders?

Kennedy-Wilson's stock is owned by many different institutional and retail investors. Top institutional investors include Mackenzie Financial Corp (2.95%), Copeland Capital Management LLC (2.07%), Invesco Ltd. (1.71%), Northern Trust Corp (1.14%), Charles Schwab Investment Management Inc. (1.10%) and Beach Investment Counsel Inc. PA (1.06%). Insiders that own company stock include Justin Enbody, Kent Y Mouton, Mary Ricks, Richard Aidan Hugh Boucher, Stanley R Zax and William J Mcmorrow.
View institutional ownership trends
.

How do I buy shares of Kennedy-Wilson?

Shares of KW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:KW) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -